DISPARATE HISTOLOGIC RESPONSES IN SIMULTANEOUSLY RESECTED PRIMARY AND METASTATIC OSTEOSARCOMA FOLLOWING INTRAVENOUS NEOADJUVANT CHEMOTHERAPY

被引：38

作者：

NACHMAN, J

SIMON, MA

DEAN, L

SHERMETA, D

DAWSON, P

VOGELZANG, NJ

机构：

[1] UNIV CHICAGO,PRITZKER SCH MED,DEPT PEDIAT,CHICAGO,IL 60637

[2] UNIV CHICAGO,PRITZKER SCH MED,DEPT MED,CHICAGO,IL 60637

[3] UNIV CHICAGO,PRITZKER SCH MED,DEPT SURG,CHICAGO,IL 60637

[4] UNIV CHICAGO,PRITZKER SCH MED,DEPT PATHOL,CHICAGO,IL 60637

来源：

关键词：

D O I：

10.1200/JCO.1987.5.8.1185

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1185 / 1190

页数：6

共 13 条

[1] KALIFA C, 1986, P INT SOC PEDIATR ON, V5, P104
[2] THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY
LINK, MP
GOORIN, AM
MISER, AW
GREEN, AA
PRATT, CB
BELASCO, JB
PRITCHARD, J
MALPAS, JS
BAKER, AR
KIRKPATRICK, JA
AYALA, AG
SHUSTER, JJ
ABELSON, HT
SIMONE, JV
VIETTI, TJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25) : 1600 - 1606
[3] PICCI P, 1985, CANCER, V56, P1515, DOI 10.1002/1097-0142(19851001)56:7<1515::AID-CNCR2820560707>3.0.CO
[4] 2-6
[5] ROSEN G, 1979, CANCER-AM CANCER SOC, V43, P2163, DOI 10.1002/1097-0142(197906)43:6<2163::AID-CNCR2820430602>3.0.CO
[6] 2-S
[7] PRIMARY OSTEOGENIC-SARCOMA OF THE FEMUR - A MODEL FOR THE USE OF PREOPERATIVE CHEMOTHERAPY IN HIGH-RISK MALIGNANT-TUMORS
ROSEN, G
CAPARROS, B
GROSHEN, S
NIRENBERG, A
CACAVIO, A
MARCOVE, RC
LANE, JM
HUVOS, AG
[J]. CANCER INVESTIGATION, 1984, 2 (03) : 181 - 192
[8] ROSEN G, 1982, CANCER-AM CANCER SOC, V49, P1221, DOI 10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO
[9] 2-E
[10] HUMAN-TUMOR CELL HETEROGENEITY AND METASTASIS
SPREMULLI, EN
DEXTER, DL
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (08) : 496 - 509